HER2 Low and HER2 Zero Patients With Operable Breast Cancer Treated With Dds-CT

Clinical trial pipeline · Data from ClinicalTrials.gov

See which HER2 Low and HER2 Zero Patients With Operable Breast Cancer Treated With Dds-CT trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

CompletedNot Applicable

NCT07561346

Clinical Outcomes and Prognostic Biomarkers Exploration Between HER2 Low and HER2 Zero eBC Patients

Although breast cancer remains one of the most common and fatal cancer types among women worldwide, earlier diagnosis and improved therapeutic approaches have l…

Greece2,751 participantsStarted 1997-07-15